Clinical Pharmacology & Therapeutics · 2007 · 360 citations · 241 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyPharmacogeneticsPharmacokinetic VariabilityAnticoagulant ManagementAnticoagulant TherapyAnticoagulation ManagementAnticoagulation TherapyClinical Implementation Of PharmacogeneticsClinical Implementation Of PharmacogenomicsBleedingClinical Pharmacology EvidenceCyp2c9 GenotypingGenotype-guided AnticoagulationGenotype-guided PrescribingSystemic AnticoagulationTherapeutic AnticoagulationTherapeutic Dose Range
Warfarin anticoagulation effect is characterized by marked variability, some of which has been attributed to CYP2C9 polymorphisms. This study prospectively examines whether a priori knowledge of CYP2C9 genotype may improve warfarin therapy. Patients were randomly assigned to receive warfarin by a validated algorithm ("control", 96 patients) or CYP2C9 genotype-adjusted algorithms ("study", 95 patients). The first therapeutic international normalized ratio and stable anticoagulation were reached 2.73 and 18.1 days earlier in the study group, respectively (P<0.001). The faster rate of initial anticoagulation was driven by a 28% higher daily dose in the study group (P<0.001). Study group patients spent more time within the therapeutic range (80.4 vs 63.4%, respectively, P<0.001) and experienced less minor bleeding (3.2 vs 12.5%, P<0.02, respectively). In conclusion, CYP2C9 genotype-guided warfarin therapy is more efficient and safer than the "average-dose" protocol. Future research should focus on construction of algorithms that incorporate other polymorphisms (VKORC1), host factors, and environmental influences.
241
Tsutomu Shimada, Hiroshi Yamazaki, Mayumi Mimura et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 2.8K citations
Medicine, Biochemistry, Pharmacology +15
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
Jessica L. Mega, Sandra Close, Stephen D. Wiviott et al. · New England Journal of Medicine · 2008 · 2.5K citations · Full text
Medicine, Cardiology, Pharmacology +17
A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy
F.R. Rosendaal, Suzanne C. Cannegieter, F.J.M. van der Meer et al. · Thrombosis and Haemostasis · 1993 · 2.1K citations · Full text